CCL5 and plasma cell myeloma: While the effects of CCL5 on malignancy may be strongly implicated in multiple myeloma and breast cancer, in which CCL5 promotes both proliferation and migration47,48, their contribution in HT29 and DLD-1 cells seems to mainly affect their motility.